ANTIBIOTICS MARKET ANALYSIS

The global antibiotics market was valued at US$ 49,081.2 Mn in 2021 and is forecast to reach a value of US$ 67,874.0 Mn by 2028 at a CAGR of 4.7% between 2022 and 2028. The global antibiotics market is experiencing strong growth unpaid to the high consumption of antibiotics and high prevalence of infectious diseases around the world. Moreover, favorable government initiatives and growing geriatric population across the globe is expected to boost the growth of the market. However, rise in incidence of antibiotic resistance and high cost of trials & research and stringent approval framework are major factors expected to hamper growth of the global antibiotics market over the forecast period.

Global Antibiotics Market: Regional Insights

Based on geography, the global antibiotics market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market over the forecast period owing to the rising incidence of infectious diseases and growing healthcare expenditure by government in the region. Antibiotics are used to fight bacterial infections. They either kill bacteria or stop them from reproducing, allowing the body to eliminate pathogens. For instance, the U.S. government is undertaking various measures to control infectious diseases, such as antibiotic stewardship initiatives and R&D activities.

Asia Pacific is also expected to witness robust growth in the global antibiotics market due to the rise in prevalence of infectious diseases, rising consumption of antibiotics, and favorable government initiatives in the region. For instance, antibiotics are widely used to prevent and treat bacterial infections. Used properly, antibiotics can save lives. India has emerged as one of the world's largest consumer of antibiotics. As per the National Center for Biotechnology Information (NCBI), India is the world's fourth largest consumer of antimicrobials for animal use, after China, U.S., and Brazil.

Figure 1. Global Antibiotics Market Share (%), by Region, 2021

To learn more about this report, request a free sample copy

Global Antibiotics Market Drivers:

High consumption of antibiotics across the globe is expected to augment growth of the global antibiotics market during the forecast period. For instance, antibiotics are medicines that fight bacterial infections in people and animals. They kill bacteria or prevent them from reproducing and spreading, and thus, there is an increase in demand for antibiotics worldwide. According to the new research conducted by the Lancet Regional Health-Southeast Asia in September 2022, Azithromycin 500mg tablet was the most consumed antibiotic formulation (7.6%) in India, followed by cefixime 200 mg tablet (6.5%).

Rising prevalence of infectious diseases around the world is expected to propel the growth of the global antibiotics market during the forecast period. For instance, antibiotics are powerful medicines that fight bacterial infections. Antibiotics are used to treat or prevent some types of bacterial infections. As per the Centers for Disease Control and Prevention (CDC), in 2020, around 7,174 new cases of tuberculosis (TB) were reported in the United States. Moreover, the common cold affects millions of people in the U.S. every year.

Global Antibiotics Market Opportunities:

Favorable government initiatives for the development of novel therapies are expected to offer significant growth opportunities for players in the antibiotics market. For instance, supportive government legislation such as the REVAMP Act and GAIN Act is expected to accelerate the process of approval, worldwide. The U.S. Food and Drug Administration (FDA) approved four new antibiotic drugs in the second half of 2019.

Growing geriatric population worldwide is expected to offer lucrative growth opportunities for players in the global antibiotics market. For instance, with the growing aging population, the burden of infectious diseases is also increasing with a rapid pace across the globe. This in turn is expected to increase the demand for antibiotics worldwide. According to the United Nations, 2019 report, there are 703 million people aged 65 or older, a number that is expected to reach around 1.5 billion by 2050.

Global Antibiotics Market Trends:

The recent trend in the global antibiotics market is the increase in development of safe, effective antibiotics owing to increase in consumption of antibiotics and rise in prevalence of infectious diseases across the globe. With the rising burden in almost every country, the consumption of antibiotics is also increasing rapidly. As a result, market players are focusing on developing and launching safe and effective antibiotics to meet increasing demand. This trend is expected to continue over the forecast period, driving the market growth.

Moreover, there is an increase in demand for newer generation of antibiotics due to increase in resistance to antibiotics, and increase in microbial resistance to antibiotics has become a major global public concern. Thus, there is an increase in demand for newer generation of antibiotics around the world. As a result, players in the market are focusing on launching novel antibiotics in the market, and this trend is expected to continue during the forecast period.

Global Antibiotics Market Restraints:

Rise in incidence of antibiotic resistance is expected to hamper growth of the global antibiotics market. For instance, antibiotic resistance is a serious public health problem. It occurs when bacteria develop the ability to survive exposure to antibiotics designed to kill them or prevent their growth. Moreover, it results in longer hospital stays, higher medical costs, and increased mortality. This in turn is expected to hinder growth of the market.

High cost of trials and research and stringent approval​ framework is expected to hinder growth of the global antibiotics market. For instance, the U.S. Food and Drug Administration (FDA) has increased the fee for Abbreviated New Drug Approval (ANDA) by around US$ 100,000 to 170,000 for the fiscal year of 2018. The hike was approved as per the Generic Drug User Fee Amendments of 2017 (GDUFA II).

Figure 2. Global Antibiotics Market Share (%), by Product Type, 2021

To learn more about this report, request a free sample copy

Global Antibiotics Market Segmentation:

The global antibiotics market report is segmented into Product, Spectrum, and Geography.

Based on Product, the market is segmented into Cephalosporins, Penicillins, Fluroquinilones, Macrolides, Carbapenems, Sulfonamides, Aminoglycosides, and Other Products. Of which, Penicillins Segment is expected to dominate the antibiotics market during the forecast period and this is attributed to the high consumption of Penicillins. Penicillin is a medication used to manage and treat a wide range of infections.

Cephalosporins Segment is also expected to witness significant growth in the near future and this is owing to the high consumption of Cephalosporin (after Penicillin). Cephalosporins are used to manage a wide range of infections from gram-positive and gram-negative bacteria.

Based on Spectrum, the antibiotics market is segmented into Broad-Spectrum Antibiotics and Narrow-Spectrum Antibiotics. Of which, Broad-Spectrum Antibiotics Segment is expected to dominate the market over the forecast period and this is attributed to the rising prevalence of infectious diseases around the world. Broad-spectrum antibiotics used to manage both gram-positive and gram-negative bacteria. Most of the doctors prescribe broad-spectrum antibiotics, as they cover a range of bacteria.

Global Antibiotics Market: Key Developments

In October 2021, Sandoz acquired GSK's cephalosporin antibiotics business. It now has the rights to three well-known brands (Zinnat, Zinacef, and Fortum) in 100 markets, strengthening its position as the world's leading antibiotics company.

In July 2019, Nosopharm and Evotec AG teamed up to develop NOSO-502. It is a first-in-class novel antibiotic against Enterobacteriaceae infections. The drug inhibits bacterial ribosome to treat nosocomial infections using polymyxin and carbapenem-resistant Enterobacteriaceae.

Global Antibiotics Market: Key Companies Insights

The global antibiotics market is highly competitive. This is attributed to the rise in demand for antibiotics and rise in consumption of antibiotics, as a result, players in the market are focusing on launching novel products in the market.

Some of the key players in the global antibiotics market are Roche Holding AG, Abbott Laboratories, Sanofi SA, Novartis AG, AstraZeneca, Pfizer Inc., Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline, and Bayer Healthcare AG, among others.

*Definition: Antibiotics are medicines that fight bacterial infections in people and animals. These drugs help destroy or slow down the growth of bacteria. Antibiotics either kill bacteria or stop them from reproducing, allowing the body to eliminate pathogens. When used properly, antibiotics can save lives.